Capital City Trust Co. FL Has $1.84 Million Holdings in Aflac Incorporated (NYSE:AFL)

Capital City Trust Co. FL lessened its stake in Aflac Incorporated (NYSE:AFLFree Report) by 1.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,800 shares of the financial services provider’s stock after selling 320 shares during the quarter. Capital City Trust Co. FL’s holdings in Aflac were worth $1,841,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Franklin Resources Inc. increased its position in Aflac by 75.2% in the 3rd quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock valued at $88,533,000 after acquiring an additional 333,083 shares in the last quarter. Aptus Capital Advisors LLC increased its position in Aflac by 79.7% in the 3rd quarter. Aptus Capital Advisors LLC now owns 27,354 shares of the financial services provider’s stock valued at $3,058,000 after acquiring an additional 12,131 shares in the last quarter. Transamerica Financial Advisors Inc. acquired a new stake in Aflac in the 3rd quarter valued at about $979,000. Roxbury Financial LLC bought a new position in shares of Aflac in the 4th quarter valued at about $948,000. Finally, FMR LLC boosted its stake in shares of Aflac by 4.0% in the 3rd quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock valued at $134,395,000 after purchasing an additional 45,745 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Stock Performance

Shares of AFL stock opened at $102.04 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The company has a market capitalization of $56.69 billion, a P/E ratio of 10.63, a price-to-earnings-growth ratio of 3.31 and a beta of 0.99. The company’s 50 day moving average price is $104.11 and its two-hundred day moving average price is $107.29. Aflac Incorporated has a 52 week low of $78.62 and a 52 week high of $115.50.

Aflac (NYSE:AFLGet Free Report) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be issued a $0.58 dividend. The ex-dividend date of this dividend is Wednesday, February 19th. This is an increase from Aflac’s previous quarterly dividend of $0.50. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.27%. Aflac’s dividend payout ratio (DPR) is 24.17%.

Insider Activity

In other news, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.90% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on AFL. Wells Fargo & Company reduced their target price on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Wednesday. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Keefe, Bruyette & Woods reduced their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 12th. Evercore ISI reduced their target price on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. Finally, Truist Financial raised their target price on shares of Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $102.86.

Read Our Latest Stock Analysis on Aflac

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

See Also

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.